about
Total synthesis of lysobactinThe discovery of new cyanobactins from Cyanothece PCC 7425 defines a new signature for processing of patellamidesNeighbor-directed histidine N (τ)-alkylation: A route to imidazolium-containing phosphopeptide macrocyclesConstraining cyclic peptides to mimic protein structure motifs.Presentation of RGDS epitopes on self-assembled nanofibers of branched peptide amphiphiles.Targeting RNA with cysteine-constrained peptides.Solid-phase synthesis of tailed cyclic RGD peptides using glutamic acid: unexpected glutarimide formation.Translation of DNA into a library of 13,000 synthetic small-molecule macrocycles suitable for in vitro selection.Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists.Cyclodepsipeptides from marine sponges: natural agents for drug researchSynthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry.Synthesis and conformation-activity relationships of the peptide isosteres of FK228 and largazole.Cyclic enkephalin-deltorphin hybrids containing a carbonyl bridge: structure and opioid activity.On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds.Synthesis, cytotoxicity and apoptosis induction in human tumor cells by galaxamide and its analogues [corrected].The taumycin A macrocycle: asymmetric total synthesis and revision of relative stereochemistry.Nature versus design: the conformational propensities of D-amino acids and the importance of side chain chirality.mRNA display selection and solid-phase synthesis of Fc-binding cyclic peptide affinity ligands.Design of growth factor sequestering biomaterialsSolid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptorsConvergent diversity-oriented side-chain macrocyclization scan for unprotected polypeptides.Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent.Enzyme-catalyzed macrocyclization of long unprotected peptides.Cyclodepsipeptides: a rich source of biologically active compounds for drug research.Peptides and Peptide Analogs to Inhibit Protein-Protein Interactions.Nonribosomal Peptide Synthesis-Principles and Prospects.Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptidesCyclization-activated prodrugs.Solid-phase total synthesis of kahalalide A and related analogues.Development of peptides specifically modulating the activity of KLK2 and KLK3.Template-constrained macrocyclic peptides prepared from native, unprotected precursorsMTI-101 (cyclized HYD1) binds a CD44 containing complex and induces necrotic cell death in multiple myelomaPeptide-based imaging agents for cancer detection.Elucidation of the Teixobactin Pharmacophore.Molecular recognition of organic ammonium ions in solution using synthetic receptorsUsing peptides to study protein-protein interactions.Contemporary strategies for peptide macrocyclization.Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.Ester coupling reactions--an enduring challenge in the chemical synthesis of bioactive natural products.Sortase A-catalyzed peptide cyclization for the synthesis of macrocyclic peptides and glycopeptides.
P2860
Q24684181-BCCF66B6-DE84-4696-8AD7-8F777BC48016Q27683489-9AD0403A-3BAE-4E6F-8F38-85ACC265FF79Q28834282-0A603B8E-A952-4434-B17F-698451F32E51Q30367509-6B12C28F-4248-413F-BB05-CEB3540D5D9CQ30483707-4DAA12EC-F104-42A4-8BEC-E7E74651CD3EQ33309127-9A502EF1-BD3E-4F91-887D-6475D103F83CQ33310713-D2E7976D-E912-49A5-9E2E-728100F61ACAQ33379897-F74FD775-1018-4A08-ADCE-83FDBBD2AC10Q33638005-B4DCA7D1-A09D-49D1-9F12-D8E40A78A1FAQ33801093-7CC4F3B3-44AF-468E-A019-80430DB490D2Q33852418-32871FF3-887F-4457-BFF6-339DC607B9FAQ33893992-A0DA0237-DF43-4CAB-BA4E-7F314F3A1398Q33902435-0809CC5F-CF85-487B-8EEB-A27AF259DF7FQ34030237-F18B7CD1-2272-487B-B01F-C0D2C05CC817Q34091891-BE489868-7772-4600-BA7E-45E70B32B216Q34285982-F80D2E65-E4C7-43CE-B732-F36625F55F37Q34378237-7ED681F2-6116-413E-9E6B-A9E0F77C3F55Q34459997-9CF907AB-D04D-47F6-95FE-325ABF0A269AQ34543371-DB66A977-53A6-47F1-A0BF-CFE3EECC575FQ34583185-D370D006-6A45-44B2-B5E1-232485F2426DQ35059832-ABD2B93B-DB66-4D0A-B8F6-5C9E23BAFBCEQ35073029-DE5A7402-4147-4812-A392-B4D7678ECD20Q35213008-B902D140-BC22-4C32-8227-9EAB89241EC8Q35231054-881888D6-C127-42C1-9B4A-F5A1AFB8B142Q36033291-0515C6BA-F489-4FB1-9613-E0D74AF17D25Q36316177-8B8BB420-54B7-4113-9D1F-A00DD97357C6Q36416681-B1F5D623-F2E1-45EA-B153-8C3179CE1FF9Q37027131-E164DB6A-6427-4C42-AF4C-CE58B4FED33CQ37029182-3C77A0E6-B396-463E-9E8B-81A4C82CE5E1Q37216674-9DCEC91F-ED26-428B-919C-56B932A1B512Q37218436-F9C578B6-5AC3-45AD-A3EE-F264D9C9755CQ37385307-6DAD340A-BFCF-433F-B55A-EE31BE86B0A6Q37585965-9560D86B-BCE9-4DEF-BABB-7EA809518BA0Q37616543-826A2C51-9F50-4B42-AB0A-206C7533F0CFQ37760795-978790A0-FA84-4B34-A51B-E86C5E83058BQ37855887-CB8826E5-ADA7-4FD9-A0FA-2C67E9E13931Q37893450-4A87CAE5-16A4-411D-80F3-E4DE7CD25C64Q38194138-DFCDF629-78B8-40A5-B6C3-FB6060628556Q38311744-4C1670AC-3DC5-4C4F-AF12-4B5E5AD5B9A7Q38451998-EAC11694-D165-4896-A0FB-5F8C169F2F24
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The cyclization of peptides and depsipeptides.
@ast
The cyclization of peptides and depsipeptides.
@en
type
label
The cyclization of peptides and depsipeptides.
@ast
The cyclization of peptides and depsipeptides.
@en
prefLabel
The cyclization of peptides and depsipeptides.
@ast
The cyclization of peptides and depsipeptides.
@en
P356
P1476
The cyclization of peptides and depsipeptides.
@en
P2093
John S Davies
P304
P356
10.1002/PSC.491
P577
2003-08-01T00:00:00Z